Association of polymorphisms of the renin-angiotensin system and bradykinin B2 receptor with ACE-inhibitor-related cough

Journal of Human Hypertension

Volumn 16, Issue 12, 2002, Pages 857-863

  Mukae, S ^a   Itoh, S ^a   Aoki, S ^a   Iwata, T ^a   Nishio, K ^a   Sato, R ^a   Katagiri, T ^a  

^a SHOWA UNIVERSITY   (Japan)

Author keywords

Angiotensin II receptor; Angiotensin converting enzyme inhibitor; Bradykinin B2 receptor; Cough; Essential hypertension; Polymorphism

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; BRADYKININ B2 RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; IMIDAPRIL; LISINOPRIL;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; COUGHING; DISEASE PREDISPOSITION; ESSENTIAL HYPERTENSION; EXON; FEMALE; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GENOTYPE; HIGH RISK PATIENT; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PROMOTER REGION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; STATISTICAL SIGNIFICANCE;

ADULT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; COUGH; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; HYPERTENSION; INCIDENCE; JAPAN; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; RECEPTOR, BRADYKININ B2; RECEPTORS, ANGIOTENSIN; RECEPTORS, BRADYKININ; RENIN-ANGIOTENSIN SYSTEM; STATISTICS;

EID: 0036959461     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1001486     Document Type: Article

References (38)

1. Vaughan DE, Pfeffer MA. Angiotensin converting enzyme inhibitors and cardiovascular remodeling. Cardiovasc Res 1994; 28: 159-165.
2. St. John Sutton M et al. Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. Circulation 1994; 89: 68-75.
3. Garg R, Yusuf S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials. JAMA 1995; 276: 1450-1456.
4. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991; 325: 293-302.
5. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993; 342: 812-828.
6. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987; 316: 1429-1435.
7. Pfeffer MA et al. Effects of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival and Ventricular Enlargement Trial. The SAVE Investigators. N Engl J Med 1992; 327: 669-677.
8. Andrejak M, Andrejak MT, Osterman G. Enalapril, captopril, and cough. Arch Intern Med 1988; 148: 249.
9. Karpman I. Cough from ACE inhibitors. Am Heart J 1988; 116: 1658.
10. McEwan JR, Choudry N, Street R, Fuller RW. Change in cough reflex after treatment with enalapril and ramipril. Br Med J 1989; 299: 13-16.
11. Furuya K et al. Angiotensin-I-converting enzyme polymorphism and susceptibility to cough. Lancet 1994; 343: 354.
12. Zee RYL et al. Three candidate genes and angiotensin-converting enzyme inhibitor-related cough. Hypertension 1998; 31: 925-928.
13. Mukae S et al. Bradykinin B2 receptor gene polymorphism is associated with angiotensin-converting enzyme inhibitor-related cough. Hypertension 2000; 36: 127-131.
14. Braun A et al. Polymorphism in the gene for the human β2-bradykinin receptor. New tools assessing a genetic risk for bradykinin-associated diseases. Immunopharmacology 1996; 33: 32-35.
15. Rigat B et al. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86: 1343-1346.
16. Doria A, Warram JH, Krolewski AS. Dde I polymorphism in the AT1R gene. Hum Mol Genet 1994; 3: 1444.
17. Takami S et al. Angiotensin II type 1 receptor gene polymorphism is associated with increase of left ventricular mass but not with hypertension. Am J Hypertens 1998; 11: 316-321.
18. Katsuya T, Horiuchi M, Minami S. Genomic organization and polymorphism of human angiotensin II type 2 receptor: No evidence for its gene mutation in two families of human premature ovarian failure syndrome. Mol Cell Endocrinol 1997; 127: 221-228.
19. Kammerer S, Braun A, Arnold N, Roscher AA. The human bradykinin β2 receptor gene: Full length cDNA, genomic organization and identification of the regulatory region. Biochem Biophys Res Commun 1995; 211: 226-233.
20. Os I et al. Cough associated with lisinopril-treatment is sex-dependent [abstract p. 102]. J Hypertens 1992; 10 (Suppl 4): S135.
21. Stoller JK, Elghazawi A, Metha A, Vidt DG. Captopril-induced cough. Chest 1988; 93: 659-661.
22. Regoli D, Rhaleb NE, Drapeau G, Dion S. Kinin receptor subtypes. J Cardiovasc Pharmacol 1990; 15 (Suppl 6): 30-38.
23. Burch RM, Kyle DJ. Mini review. Recent development in the understanding of bradykinin receptors. Life Sci 1992; 50: 829-838.
24. Eggerickx D et al. Molecular cloning, functional expression and pharmacological characterization of a human bradykinin B2 receptor gene. Biochem Biophys Res Commun 1992; 187: 1306-1313.
25. Hess JF et al. Cloning and pharmacological characterization of a human bradykinin (BK-2) receptor. Biochem Biophys Res Commun 1992; 184: 260-268.
26. Powell SJ et al. Human bradykinin B2 receptor: Nucleotide sequence analysis and assignment to chromosome 14. Genomics 1993; 15: 435-438.
27. Ma JX, Wang DZ, Chao L, Chao J. Cloning, sequence analysis and expression of the gene encoding the mouse bradykinin B2 receptor. Gene 1994; 149: 283-288.
28. Ma JX et al. Structure and chromosomal localisation of the gene (BDKRB2) encoding human bradykinin B2 receptor. Genomics 1994; 23: 362-369.
29. Pesquero JB et al. Molecular structure and expression of bradykinin B2 receptor gene. J Biol Chem 1994; 269: 26 920-26 925.
30. Mukae S et al. Promoter polymorphism of the B2 bradykinin receptor gene is associated with essential hypertension. J Circ J 1999; 63: 759-762.
31. Gainer JV et al. Altered frequency of a promoter polymorphism of the kinin B2 receptor gene in hypertensive African-Americans. Am J Hypertens 2000; 13: 1268-1273.
32. Okumura H et al. No relation between angiotensin-converting enzyme (ACE) inhibitor-induced cough and ACE gene polymorphism, plasma bradykinin, substance P and ACE inhibitor concentration in Japanese patients. Yakugaku Zassshi 2001; 121: 253-257.
33. Tiret L et al. Deletion polymorphism in angiotensin-converting enzyme gene associated with parental history of myocardial infarction. Lancet 1993; 341: 991-992.
34. Bonnardeaux A et al. Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. Hypertension 1994; 24: 63-69.
35. Jalowy A et al. Infarct size reduction by AT1-receptor blockade through a signal cascade of AT2-receptor activation, bradykinin and prostaglandins in pigs. J Am Coll Cardiol 1998; 32: 1787-1796.
36. Tsutsumi Y et al. Angiotensin II type 2 receptor is upregulated in human heart with interstitial fibrosis, and cardiac fibroblasts are the major cell type for its expression. Circ Res 1998; 83: 1035-1046.
37. Kuizinga MC, Smits JFM, Arends JW, Daemen MJAP: AT2-receptor blockade reduces cardiac interstitial cell DNA synthesis and cardiac function after rat myocardial infarction. J Mol Cell Cardial 1998; 30: 425-434.
38. Lee YJ, Tsai JCR. Angiotensin-converting enzyme gene insertion/deletion, not bradykinin B2 receptor -58T/C gene polymorphism, associated with angiotensin-converting enzyme inhibitor-related cough in Chinese female patients with non-insulin-dependent diabetes mellitus. Metabolism 2001; 50: 1346-1350.